On August 3, the Accreditation Council for CME sent a letter to the U.S. Senate Committee on Finance to address the committee’s concerns about CME. In a report issued in April and a subsequent letter to the ACCME, the SFC expressed reservations about the ACCME's oversight of continuing medical activities, suggesting that it was insufficient to guarantee that programs are independent of drug company influence. The ACCME's letter outlined a five-step action plan for analyzing and improving ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.